| Weinmann-Menke, Julia |
TaC:Drop, NCT06268769: Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs |
|
|
| Recruiting | 4 | 300 | Europe | Tacrolimus Pill, Envarsus, Tacrolimus capsule, Advagraf | Edward Geissler, Chiesi Pharmaceuticals GmbH | Immunosuppression | 12/26 | 09/29 | | |
BE-EARLY, NCT06411249: A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) |
|
|
| Recruiting | 4 | 350 | Europe, Japan, US, RoW | Belimumab (GSK1550188), BEL (BENLYSTA) | GlaxoSmithKline | Systemic Lupus Erythematosus | 04/27 | 05/29 | | |
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) |
|
|
| Recruiting | 3 | 10000 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | 02/29 | 02/29 | | |
TOPAZ-2, NCT04961567 / 2020-005776-35: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus |
|
|
| Recruiting | 3 | 540 | Europe, Canada, Japan, US, RoW | Litifilimab, BIIB059, Placebo | Biogen | Lupus Erythematosus, Systemic | 09/25 | 03/26 | | |
| Recruiting | N/A | 14 | Europe | Hemodialysis, ADVOS | University Medical Center Mainz, ADVITOS GmbH München | Liver Cirrhosis, Kidney Failure, Acute, Kidney Replacement, Multi Organ Failure | 06/25 | 06/26 | | |
| Active, not recruiting | N/A | 40 | Europe | Immunoadsorption, Sham-apheresis | University Medical Center Mainz | Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition | 12/24 | 03/25 | | |
| Recruiting | N/A | 206 | Europe | Repeat kidney biopsy | Karolinska Institutet, Université Catholique de Louvain | Lupus Nephritis | 12/28 | 12/28 | | |
| Allton, Pamela |
NCT05251727: Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients |
|
|
| Terminated | 1 | 77 | Japan, US | thrombomodulin alfa, ART-123, Placebo | Veloxis Pharmaceuticals | Chemotherapy-induced Peripheral Neuropathy | 06/24 | 06/24 | | |
| Haraguchi, Mikiko |
NCT05326230: A Clinical Study of the Paradise™ Renal Denervation System in Patients with Hypertension (RADIANCE-HTN DUO) |
|
|
| Recruiting | N/A | 154 | Japan | Paradise™ (PRDS-001) Renal Denervation Ultrasound System, Renal Angiogram/Renal Denervation, Renal Angiogram | Otsuka Medical Devices Co., Ltd. Japan | Hypertension, Vascular Diseases, Cardiovascular Diseases | 12/25 | 12/29 | | |
NCT05759819: Evaluate the Efficacy and Safety of the Cilostazol-coated BioMimics 3D Stent System in Patients With Peripheral Arterial Occlusive Disease |
|
|
| Active, not recruiting | N/A | 24 | Japan | Standard stenting | Otsuka Medical Devices Co., Ltd. Japan | Peripheral Arterial Disease | 12/24 | 12/26 | | |
| Ishinabe, Kentaro |
NCT06589505: Software as a Medical Device for the Treatment of Patients With PTSD |
|
|
| Recruiting | 2/3 | 52 | Japan | Software as a Medical Device | Otsuka Medical Devices Co., Ltd. Japan, Otsuka Pharmaceutical Co., Ltd. | Post-Traumatic Stress Disorder, PTSD | 01/28 | 01/28 | | |
NCT05326230: A Clinical Study of the Paradise™ Renal Denervation System in Patients with Hypertension (RADIANCE-HTN DUO) |
|
|
| Recruiting | N/A | 154 | Japan | Paradise™ (PRDS-001) Renal Denervation Ultrasound System, Renal Angiogram/Renal Denervation, Renal Angiogram | Otsuka Medical Devices Co., Ltd. Japan | Hypertension, Vascular Diseases, Cardiovascular Diseases | 12/25 | 12/29 | | |
